Screening for Colorectal Neoplasias with Fecal Occult Blood Tests: False-positive Impact of Non-Dietary Restriction

被引:9
|
作者
Roslani, April Camilla [1 ]
Abdullah, Taufiq [2 ]
Arumugam, Kulenthran [1 ]
机构
[1] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia
[2] Univ Malaya, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia
关键词
Colorectal cancer; fecal occult blood test; screening; diet restriction; CANCER STATISTICS; CONTROLLED TRIAL; COLONOSCOPY; POPULATION; SURVIVAL;
D O I
10.7314/APJCP.2012.13.1.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 % and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 50 条
  • [31] Does warfarin increase the rate of false positive fecal occult blood tests? A prospective endoscopic study
    Bini, EJ
    Rajapaksa, RC
    Weinshel, EH
    GASTROINTESTINAL ENDOSCOPY, 2001, 53 (05) : AB58 - AB58
  • [32] Efficacy of a Single Day Fecal Immunochemical Occult Blood Testing (FIT) Collection Strategy for Screening Relevant Colorectal Neoplasias
    Wong, Clarence K.
    Fedorak, Richard N.
    Prosser, Connie I.
    van Zanten, Sander Veldhuyzen
    Sadowski, Daniel C.
    GASTROENTEROLOGY, 2011, 140 (05) : S410 - S410
  • [33] Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: The patient perspective
    Deutekom, Marije
    van Rossum, Leo G. M.
    van Rijn, Anne F.
    Laheij, Robert J. F.
    Fockens, Paul
    Bossuyt, Patrick M. M.
    Dekker, Evelien
    Jansen, Jan B. M. J.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (11) : 1345 - 1349
  • [34] A Population-based Comparison of Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening
    Raginel, Thibaut
    Puvinel, Josette
    Ferrand, Olivier
    Bouvier, Veronique
    Levillain, Romuald
    Ruiz, Angela
    Lantieri, Olivier
    Launoy, Guy
    Guittet, Lydia
    GASTROENTEROLOGY, 2013, 144 (05) : 918 - 925
  • [35] Analytical Comparison of Three Quantitative Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening
    Guittet, Lydia
    Guillaume, Elodie
    Levillain, Romuald
    Beley, Philippe
    Tichet, Jean
    Lantieri, Olivier
    Launoy, Guy
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (07) : 1492 - 1501
  • [36] Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
    Kathy L Flitcroft
    Les M Irwig
    Stacy M Carter
    Glenn P Salkeld
    James A Gillespie
    BMC Gastroenterology, 12
  • [37] Colorectal cancer screening in asymptomatic adults: Comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests
    Cheng, TI
    Wong, JM
    Hong, CF
    Cheng, SH
    Chen, TJ
    Shieh, MJ
    Lin, YM
    Tso, CY
    Huang, AT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (10) : 685 - 690
  • [38] Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea
    Nhung Cam Bui
    Cho, Ha Na
    Lee, Yoon Young
    Suh, Mina
    Park, Boyoung
    Jun, Jae Kwan
    Kim, Yeol
    Choi, Kui Son
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 416 - 427
  • [39] A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening
    Church, TR
    Yeazel, MW
    Jones, RM
    Kochevar, LK
    Watt, GD
    Mongin, SJ
    Cordes, JE
    Engelhard, D
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (10): : 770 - 780
  • [40] Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
    Flitcroft, Kathy L.
    Irwig, Les M.
    Carter, Stacy M.
    Salkeld, Glenn P.
    Gillespie, James A.
    BMC GASTROENTEROLOGY, 2012, 12